MX337367B - El uso de compuestos de 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pirimi dina para combatir pestes en y sobre animales. - Google Patents

El uso de compuestos de 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pirimi dina para combatir pestes en y sobre animales.

Info

Publication number
MX337367B
MX337367B MX2010006876A MX2010006876A MX337367B MX 337367 B MX337367 B MX 337367B MX 2010006876 A MX2010006876 A MX 2010006876A MX 2010006876 A MX2010006876 A MX 2010006876A MX 337367 B MX337367 B MX 337367B
Authority
MX
Mexico
Prior art keywords
halogeno
triazolo
animals
pyrimidine compounds
combating pests
Prior art date
Application number
MX2010006876A
Other languages
English (en)
Other versions
MX2010006876A (es
Inventor
Albert Boeckh
Mark David Soll
Ernst Baumann
Matthias Pohlman
Jeffrey Norman Clark
Kerrie Maria Powell
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MX2010006876A publication Critical patent/MX2010006876A/es
Publication of MX337367B publication Critical patent/MX337367B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se relaciona al uso de compuestos de 6-halágeno-[1,2,4]-triazolo-[l,5-a]-pirimidina de la fórmula general (I), en donde A, R1, R2, R3 y R4 son como se definen en la especificación; y/o un enantiómero, diastereómero, tautómero, solvato, forma cristalina o sal veterinariamente aceptable de los mismos, solos o en combinación con un agente anti-parasiticida para combatir parásitos en y sobre animales.
MX2010006876A 2007-12-21 2008-12-11 El uso de compuestos de 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pirimi dina para combatir pestes en y sobre animales. MX337367B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1609107P 2007-12-21 2007-12-21
PCT/EP2008/067326 WO2009080546A1 (en) 2007-12-21 2008-12-11 The use of 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pyrimidine compounds for combating pests in and on animals

Publications (2)

Publication Number Publication Date
MX2010006876A MX2010006876A (es) 2011-02-21
MX337367B true MX337367B (es) 2016-02-29

Family

ID=40265981

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006876A MX337367B (es) 2007-12-21 2008-12-11 El uso de compuestos de 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pirimi dina para combatir pestes en y sobre animales.

Country Status (12)

Country Link
US (1) US20110028495A1 (es)
EP (1) EP2237774B1 (es)
AR (1) AR071928A1 (es)
AU (1) AU2008340434B2 (es)
CA (1) CA2710171C (es)
CL (1) CL2008003864A1 (es)
ES (1) ES2584930T3 (es)
HK (1) HK1149210A1 (es)
MX (1) MX337367B (es)
NZ (1) NZ586527A (es)
TW (1) TW200944208A (es)
WO (1) WO2009080546A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI624878B (zh) * 2011-03-11 2018-05-21 半導體能源研究所股份有限公司 半導體裝置的製造方法
WO2017000277A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Substituted triazolo bicycliccompounds as pde2 inhibitors
BR112021012021A2 (pt) * 2018-12-18 2021-09-21 Elanco Tiergesundheit Ag Derivados bicíclicos

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD99794A1 (es) 1966-09-27 1973-08-20
FR1567021A (es) 1967-01-27 1969-05-16
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US6372774B1 (en) 1985-12-20 2002-04-16 Rhone-Poulenc Agriculture Ltd. Derivatives of N-phenylpyrazoles
US5232940A (en) 1985-12-20 1993-08-03 Hatton Leslie R Derivatives of N-phenylpyrazoles
US5547974A (en) 1985-12-20 1996-08-20 Rhone-Poulenc Agriculture Ltd. Derivatives of N-phenylpyrazoles
GB8713768D0 (en) 1987-06-12 1987-07-15 May & Baker Ltd Compositions of matter
AR243191A1 (es) 1986-03-25 1993-07-30 Sankyo Co Procedimiento para preparar compuestos de macrolida
EP0252879B1 (de) 1986-07-02 1992-05-06 Ciba-Geigy Ag Pestizide
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5299582A (en) 1991-09-16 1994-04-05 Little Rapids Corporation Surgical isolation apparatus
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5595991A (en) 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
EP0819000B1 (en) 1995-03-20 2009-07-08 Merck & Co., Inc. Nodulisporic acid derivatives
US5834260A (en) 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
US6136838A (en) 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
US6399796B2 (en) 2000-03-17 2002-06-04 Roche Vitamins Inc. Activation of a Diels-Alder reaction of a sterol 5,7-diene
DE10106455A1 (de) * 2001-02-13 2002-08-14 Bayer Ag DELTA·1·-Pyrroline
GB0126914D0 (en) * 2001-11-08 2002-01-02 Syngenta Ltd Fungicides
UY28506A1 (es) * 2003-09-12 2005-04-29 Basf Ag 6-halógeno-(1,2,4)triazolo(1,5-a)pirimidinas para combatir plagas animales.
EP1994017A2 (en) * 2006-03-15 2008-11-26 4Sc Ag Novel heterocyclic nf-kb inhibitors
US20080027079A1 (en) * 2006-06-22 2008-01-31 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

Also Published As

Publication number Publication date
CA2710171A1 (en) 2009-07-02
CL2008003864A1 (es) 2010-06-11
WO2009080546A1 (en) 2009-07-02
AR071928A1 (es) 2010-07-28
AU2008340434A1 (en) 2009-07-02
US20110028495A1 (en) 2011-02-03
HK1149210A1 (zh) 2011-09-30
MX2010006876A (es) 2011-02-21
EP2237774A1 (en) 2010-10-13
EP2237774B1 (en) 2016-06-22
CA2710171C (en) 2016-02-02
NZ586527A (en) 2011-11-25
TW200944208A (en) 2009-11-01
AU2008340434B2 (en) 2014-02-06
ES2584930T3 (es) 2016-09-30

Similar Documents

Publication Publication Date Title
IL278119B (en) Disubstituted pyrazolo[5.1–a]pyrimidine compounds as trk kinase inhibitors
WO2007143705A3 (en) Organic compounds
AP2010005346A0 (en) 3H-[1,2,3]triazolo[4,5-D]pyrimidine compounds, their use as mTOR kinase and P13 kinase inhibitors, and their synthesis.
TN2011000245A1 (en) Organic compounds
EP2078721A3 (en) Thieno-pyrimidime compounds having fungicidal activity
MY146474A (en) Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
WO2007023382A3 (en) Pyrimidine amino pyrazole compounds, potent kinase inhibitors
SG170739A1 (en) Iap bir domain binding compounds
EP2258372B8 (en) A2A antagonists for use in the treatment of motor disorders
WO2006116733A3 (en) Protein kinase inhibitors
WO2010121576A3 (en) Novel 7-deazapurine nucleosides for therapeutic uses
MX2010009458A (es) Derivados biciclicos heterociclicos o espirobiciclicos heterociclicos enlazados, de pirazolo[1,5-a]pirimidinas, procedimientos para su preparacion y usos de los mismos.
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
ZA201004368B (en) Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
MX2012004089A (es) Inhibidores de hsp90.
WO2008048589A3 (en) Compounds and methods for treatment of hcv
PL1932522T3 (pl) Środek terapeutyczny do leczenia choroby wątroby zawierający jako składnik czynny pochodną 2-amino-1,3-propanodiolu
TW200728298A (en) Thiophene compounds and thrombopoietin receptor activators
WO2008126901A1 (ja) 含窒素複素環化合物およびそれを含有する医薬組成物
WO2009156951A3 (en) 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
WO2006088903A3 (en) Pyrazole compounds
IL174196A0 (en) 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
WO2008116185A3 (en) Substituted pyrimidines as adenosine receptor antagonists
WO2008104473A3 (en) Pyrazolopyriidine derivatives and their use as kinase inhibitors
WO2008109856A3 (en) Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions

Legal Events

Date Code Title Description
FG Grant or registration